A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT)

Thrombosis and Haemostasis

Volumn 82, Issue 4, 1999, Pages 1255-1259

  Jy, Wenche ^a   Mao, Wei Wei ^a   Horstman, Lawrence L ^a   Valant, Peter A ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

CD36; CD62; Drug induced antibodies; Heparin; Heparin induced thrombocytopenia; P selectin; Platelet activation; Thrombocytopenia; Thrombosis

Indexed keywords

HEPARIN; PADGEM PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPARINIZATION; HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0032863073     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614371     Document Type: Article

References (38)

1. Warkentin TE, Kelton JG: Heparin-induced thrombocytopenia. Progr Hemost Thromb 1991; 10: 1-34.
2. Chong BH. Heparin-induced thrombocytopenia. Br J Haematol 1995; 89: 431-9.
3. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: Towards consensus. Thromb Haemost 1998; 79: 1-7.
4. Walenga JM, Bick RL. Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy. Med Clinics North Amer 1998; 82: 635-57.
5. Alving BM, Krishnamurti C. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis. Semin Thromb Hemost 1997; 23: 569-74.
6. Kelton JG, Warkentin TE. Diagnosis of heparin-induced thrombocytopenia: Still a journey, not yet a destination (Editorial). Amer J Clin Path 1995; 104: 611-3.
7. Chong BH, Eisbacher M. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia. Sem Hematol 1998; 35 (No 4, Supl 5): 3-8.
8. Vermylen J, Hoylaerts MF, Arnout J. Antibody-mediated thrombosis. Thromb Haemost 1997; 78: 420-6.
9. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia (letter). Thromb Haemost 1992; 68: 95-6.
10. Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Mueller-Eckhardt C. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation lest, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 1994; 34: 381-5.
11. Amiral J, Bridey F, Wolf M, Buyer-Neumann C, Ftressinaud E, Vissac AM, Paynaud-Debayle E, Dreyfus M, Meyer D. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost 1995; 73: 21-8.
12. Kelton JG, Smith JW, Warkentin TE, Hay way C, Denomme GA, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994; 83: 3232-9.
13. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93: 81-8.
14. 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood 1997; 89: 370-5.
15. Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG. Heparin-induced thrombocytopenia; Laboratory studies. Blood 1988; 72: 925-30.
16. Chong BH, Fawaz I, Chesterman CN, Berndt MC. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 1989; 73: 235-40.
17. Greinacher A, Michels I, Liebenhoff U, Presek P, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulfated oligosaccharides. Br J Haematol 1993; 84: 711-6.
18. Sheridan D, Carter CJ, Kelton JC. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27-30.
19. Stewart MW, Etches WS, Boshkov LK, Gordon PA. Heparin-induced thrombocytopenia: an improved method of detection based on lumi-aggregometry. Br J Haematol 1995; 91: 173-7.
20. Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JAI, Bode AP, Kelton JG. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 84: 3691-9.
21. Fratantoni JC, Pollet R, Gralnick HR. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood 1975; 45: 395-401.
22. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993; 69: 344-50.
23. Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: a receptor that mediates the interaction of platelets with neutrophils and monocytes. Cell 1989; 59: 305-12.
24. Mao WW, Jy W, Kolodny L, Horstman L, Valant P, Ahn YS. Discrimination of heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT) by flow cytometric analysis of activation marker CD62P. Thromb Haemost 1997; 77(supl): 448. (Presented at XVI congress of Int Soc Thromb Haemost, June, 1997, Florence, Italy.)
25. Mao WW, Jy W, Horstman LL, Valant P, Ahn YS. Flow cytometric assay of P-selectin (CD62P) appears useful in distinguishing heparin induced thrombocytopenia with thrombosis (HITT) from heparin induced thrombocytopenia (HIT). Platelets 1998; 9: 417.
26. White MM, Siders L, Jennings LK, White FL. The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associaled thrombocytopenia (Letter). Thromb Haemost 1992; 68: 88.
27. Jy W, Horstman LL, Park H, Mao WW, Valant P, Ahn YS. Platelet aggregates as markers of platelet activation: Characterization of flow cytometric method suitable for clinical applications. Am J Hematol 1998; 57: 33-42.
28. Valant PA, Jy W, Horstman LL, Mao WW, Ahn YS. Thrombotic thrombocytopenic purpura (TTP) plasma enhances platelet-leukocyte interaction in vitro. Br J Haematol 1998; 100: 24-32.
29. Arepally G, Reynolds C, Tomaski A, Amiral J, Jawad A, Poncz M, Cines DB. Comparison of PF4 / heparin ELISA assay with the 14-C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1995; 104: 648-54.
30. Boshkov LK, Warkentin TE, Hayward CPM, Andrew M. Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Haematol 1993; 84: 322-8.
31. Schultz DR, Arnold Pl, Jy W, Valant P, Gruber J, Ahn YS. Mao FW, Mao WW, Horstman LL. Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders: identification of an 85 kD form of CD36 as a target antigen. Br J Haematol 1998, 103: 849-57.
32. Ahn YS, Jy W, Kolodny L, Horstman LL, Mao WW, Valant PA. Activated platelet aggregates in thrombotic thrombocytopenic purpura: decrease with plasma infusions and normalization in remission. Br J Haematol 1996; 95: 408-15.
33. Greenwalt DE, Kipsly RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992; 80: 1105-15.
34. Amiral J, Marfaing-Koka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 1996; 88: 410-6.
35. Visentin GP, Moghaddam M, Collins JL, McFarland JG, Aster RH. Antibodies associated with heparin-induced thrombocytopenia (HIT) report conformational changes in platelet factor 4 (PF4) induced by linear polyanionic compounds. Blood 1997; 90(Suppl 1): 460a.
36. Saffroy R, Bachelot-Loza C, Fridman WH, Aiach M, Teillaud JL, Rendu F. Plasma levels of soluble Fc(gamma) receptors II (sCD32) and III (sCD16) in patients with heparin-induced thrombocytopenia. Thromb Haemost 1997: 78: 970-1.
37. Bachelot-Loza C, Saffroy R, Lasne D, Chatellier G, Aiach M, Rendu F. Importance of the Rc(gamma) RII-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis. Thromb Haemost 1998; 79: 523-8.
38. Lee DH, Warkentin TE, Denomme GA, Lagrotteria DD, Kelton JG. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia. Thromb Haemost 1998; 79; 50-3.